10 May, 2014 by The TZ Newswire Staff Comments Off on MannKind Corporation Earnings: Are Better Times Ahead?
MannKind Corporation Earnings: Are Better Times Ahead?
Investors in the biotech company have waited a long time for success, but will it ever come?
10 May, 2014 by The TZ Newswire Staff Comments Off on See’s Candies: A Sweet Investment for Berkshire
See’s Candies: A Sweet Investment for Berkshire
Buffett spent $25 million investment in 1972 to buy See’s Candies, and the $1.7 billion of pre-tax earnings that it has generated since then are just the tip of the iceberg
10 May, 2014 by The TZ Newswire Staff Comments Off on Low Mortgage Rates Fail to Ignite Mortgage Applications or Home Sales
Low Mortgage Rates Fail to Ignite Mortgage Applications or Home Sales
10 May, 2014 by The TZ Newswire Staff Comments Off on Meet the guys making fun of Silicon Valley
Meet the guys making fun of Silicon Valley
CNBC met up with the executive producers and stars of HBO’s new show Silicon Valley to find out what real-world tech they actually use.
10 May, 2014 by The TZ Newswire Staff Comments Off on A financial advisor’s job isn’t to make you money
A financial advisor’s job isn’t to make you money
A savvy financial advisor should help you leverage your wealth to attain your key life goals.
10 May, 2014 by The TZ Newswire Staff Comments Off on Under fire, Pfizer hits back as it weighs next Astra move
Under fire, Pfizer hits back as it weighs next Astra move
U.S. drugmaker Pfizer (PFE) fought back on Saturday against criticism that its planned takeover of rival AstraZeneca (AZN.L) would damage Britain’s science base by saying strong UK research was a key reason for the deal. Given its record of big job cuts after past acquisitions, the U.S. group has come under fire in Britain, the United States and Sweden as it weighs its next move to buy AstraZeneca, which could be a sweetened offer next week.
10 May, 2014 by The TZ Newswire Staff Comments Off on UK finance minister ready for ‘hard negotiation’ with Pfizer
UK finance minister ready for ‘hard negotiation’ with Pfizer
Britain is ready for \”hard negotiation\” to ensure Pfizer sticks to specific promises on jobs and science under the U.S. drugmaker’s proposed takeover of AstraZeneca, its finance minister said. \”I think it would be extraordinary not to engage with AstraZeneca or Pfizer,\” George Osborne told BBC radio on Saturday. He stressed Britain was an open economy that had benefited \”enormously\” from past investment by foreign companies, such as Tata Motors and Nissan in the car industry, and AstraZeneca itself had grown by taking over foreign firms.